Cescon DW - Search Results

1

Influence of control group therapy on the benefit from dose-dense chemotherapy in early breast cancer: a systemic review and meta-analysis.

Goldvaser H, Majeed H, Ribnikar D, Šeruga B, Ocaña A, Cescon DW, Amir E. Goldvaser H, et al. Among authors: cescon dw. Breast Cancer Res Treat. 2018 Jun;169(3):413-425. doi: 10.1007/s10549-018-4710-5. Epub 2018 Feb 8. Breast Cancer Res Treat. 2018. PMID: 29423899 Review.

2

Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer.

Seruga B, Hertz PC, Wang L, Booth CM, Cescon DW, Krzyzanowska M, Tannock IF. Seruga B, et al. Among authors: cescon dw. Ann Oncol. 2010 Jul;21(7):1411-1418. doi: 10.1093/annonc/mdp552. Epub 2009 Nov 30. Ann Oncol. 2010. PMID: 19951955 Free article.

3

Pharmacogenetic and germline prognostic markers of lung cancer.

Horgan AM, Yang B, Azad AK, Amir E, John T, Cescon DW, Wheatley-Price P, Hung RJ, Shepherd FA, Liu G. Horgan AM, et al. Among authors: cescon dw. J Thorac Oncol. 2011 Feb;6(2):296-304. doi: 10.1097/JTO.0b013e3181ffe909. J Thorac Oncol. 2011. PMID: 21206385 Free article.

4

Feasibility of a randomized controlled trial of vitamin D vs. placebo in women with recently diagnosed breast cancer.

Cescon DW, Ganz PA, Beddows S, Ennis M, Mills BK, Goodwin PJ. Cescon DW, et al. Breast Cancer Res Treat. 2012 Jul;134(2):759-67. doi: 10.1007/s10549-012-2120-7. Epub 2012 Jun 16. Breast Cancer Res Treat. 2012. PMID: 22706631

5

Extended adjuvant tamoxifen for early breast cancer: a meta-analysis.

Al-Mubarak M, Tibau A, Templeton AJ, Cescon DW, Ocana A, Seruga B, Amir E. Al-Mubarak M, et al. Among authors: cescon dw. PLoS One. 2014 Feb 20;9(2):e88238. doi: 10.1371/journal.pone.0088238. eCollection 2014. PLoS One. 2014. PMID: 24586311 Free PMC article.

6

NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma.

Cescon DW, She D, Sakashita S, Zhu CQ, Pintilie M, Shepherd FA, Tsao MS. Cescon DW, et al. Clin Cancer Res. 2015 Jun 1;21(11):2499-505. doi: 10.1158/1078-0432.CCR-14-2206. Epub 2015 Mar 4. Clin Cancer Res. 2015. PMID: 25739673

7

Capecitabine in early breast cancer: A meta-analysis of randomised controlled trials.

Natori A, Ethier JL, Amir E, Cescon DW. Natori A, et al. Among authors: cescon dw. Eur J Cancer. 2017 May;77:40-47. doi: 10.1016/j.ejca.2017.02.024. Epub 2017 Mar 27. Eur J Cancer. 2017. PMID: 28355581 Review.

8

Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis.

Goldvaser H, Barnes TA, Šeruga B, Cescon DW, Ocaña A, Ribnikar D, Amir E. Goldvaser H, et al. Among authors: cescon dw. J Natl Cancer Inst. 2018 Jan 1;110(1). doi: 10.1093/jnci/djx141. J Natl Cancer Inst. 2018. PMID: 28922781 Review.

9

Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer.

Pezo RC, Chen TW, Berman HK, Mulligan AM, Razak AA, Siu LL, Cescon DW, Amir E, Elser C, Warr DG, Sridhar SS, Yu C, Wang L, Stockley TL, Kamel-Reid S, Bedard PL. Pezo RC, et al. Among authors: cescon dw. Breast Cancer Res Treat. 2018 Feb;168(1):159-168. doi: 10.1007/s10549-017-4580-2. Epub 2017 Nov 24. Breast Cancer Res Treat. 2018. PMID: 29177603 Free PMC article.

10

Evolution in sites of recurrence over time in breast cancer patients treated with adjuvant endocrine therapy.

Algorashi I, Goldvaser H, Ribnikar D, Cescon DW, Amir E. Algorashi I, et al. Among authors: cescon dw. Cancer Treat Rev. 2018 Nov;70:138-143. doi: 10.1016/j.ctrv.2018.08.009. Epub 2018 Aug 24. Cancer Treat Rev. 2018. PMID: 30176513 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

126 results

Search Page